Aquarius Surgical Technologies Inc.
ASTI
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -56.73% | -47.59% | -20.45% | 15.53% | -2.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -56.73% | -47.59% | -20.45% | 15.53% | -2.25% |
| Cost of Revenue | -40.86% | -33.28% | -15.53% | -33.33% | -42.18% |
| Gross Profit | -65.35% | -56.41% | -24.42% | 89.98% | 56.42% |
| SG&A Expenses | -7.45% | 1.96% | -18.02% | -6.35% | -20.08% |
| Depreciation & Amortization | -8.30% | 4.27% | 40.63% | 114.95% | 294.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.96% | -1.85% | -16.15% | -7.33% | -20.42% |
| Operating Income | -8.20% | -16.92% | 14.77% | 13.11% | 26.15% |
| Income Before Tax | -49.87% | -38.11% | -16.69% | -8.92% | -1.44% |
| Income Tax Expenses | -83.58% | 246.67% | 246.67% | 246.67% | -- |
| Earnings from Continuing Operations | -48.31% | -38.80% | -17.36% | -9.61% | -2.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.31% | -38.80% | -17.36% | -9.61% | -2.65% |
| EBIT | -8.20% | -16.92% | 14.77% | 13.11% | 26.15% |
| EBITDA | -8.85% | -17.68% | 16.17% | 15.62% | 28.45% |
| EPS Basic | -49.26% | -39.53% | -12.44% | -0.95% | 9.38% |
| Normalized Basic EPS | -11.90% | -21.43% | 2.78% | 13.07% | 23.64% |
| EPS Diluted | -49.26% | -39.53% | -12.44% | -0.95% | 9.38% |
| Normalized Diluted EPS | -11.90% | -21.43% | 2.78% | 13.07% | 23.64% |
| Average Basic Shares Outstanding | 0.00% | 0.05% | 2.95% | 6.85% | 11.07% |
| Average Diluted Shares Outstanding | 0.00% | 0.05% | 2.95% | 6.85% | 11.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |